Abstract
Abstract
Background
Early detection of intermediate hyperglycaemia, otherwise known as non-diabetic hyperglycaemia (NDH) is crucial to identify people at high risk of developing type 2 diabetes mellitus (T2DM) who could benefit from preventative interventions. Failure to identify NDH may also increase the risks of T2DM-related complications at the time of T2DM diagnosis. We investigate sociodemographic inequalities in identification of NDH in England.
Methods
We used nationwide data from the English National Health Service (NHS) National Diabetes Audit, which includes all people who were newly identified with NDH (N = 469,910) or diagnosed with T2DM (N = 222,795) between 1st April 2019 and 31st March 2020. We used regression models to explore inequalities in the under identification of NDH by area-level deprivation and age group.
Results
Of those with a new T2DM diagnosis, 67.3% had no previous record of NDH. The odds of no previous NDH being recorded were higher amongst people living in more deprived areas (Odds ratio (OR) 1.15 (95% confidence intervals (CI) [1.12, 1.19]) most deprived (Q1) compared to least deprived (Q5) quintile) and younger individuals (OR 4.02 (95% CI [3.79, 4.27] under 35s compared to age 75–84)). Deprivation-related inequalities persisted after stratification by age group, with the largest inequalities amongst middle and older age groups. People living in more deprived areas and younger people also had shorter recorded NDH duration before progression to T2DM, and higher T2DM severity at the time of diagnosis.
Conclusions
There is under identification of NDH relative to diagnosis of T2DM amongst people living in more deprived areas and particularly amongst younger people, resulting in missed opportunities for targeted T2DM prevention efforts and potentially contributing to inequalities in T2DM prevalence and severity. More active NDH case-finding amongst these groups may be an important first step in helping to reduce inequalities in T2DM.
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Public Health England, Diabetes UK, NHS England. NHS Diabetes Prevention Programme overview and FAQ. https://www.england.nhs.uk/wp-content/uploads/2016/08/dpp-faq.pdf. Accessed 26 Apr 2023.
2. World Health Organization, International Diabetes Federation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation. World Health Organization; 2006. https://www.who.int/publications-detail-redirect/definition-and-diagnosis-of-diabetes-mellitus-andintermediate-hyperglycaemia. Accessed 12 June 2024.
3. Bergman M, Manco M, Satman I, et al. International Diabetes Federation Position Statement on the 1-hour post-load plasma glucose for the diagnosis of intermediate hyperglycaemia and type 2 diabetes. Diabetes Res Clin Pract. 2024;209: 111589.
4. NHS Digital. Non-diabetic hyperglycaemia, 2020–21 diabetes prevention programme. 2022. https://files.digital.nhs.uk/A3/2822C7/NDA_NDH-DPP_AnnualReport_2021.pdf. Accessed 26 Apr 2023.
5. McManus E, Meacock R, Parkinson B, Sutton M. Population level impact of the NHS Diabetes Prevention Programme on incidence of type 2 diabetes in England: an observational study. Lancet Reg Health Eur. 2022;19: 100420.